Why The FDA Can’t Be Flexible With 23andMe, By Law
David Kroll, forbes.com“One of the challenges is the world has been evolving and yet we have legislation that reflects a different era.”– Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
Almost a year ago, at the inaugural Forbes…
Related articles
- Why The FDA Can’t Be Flexible With 23andMe, By Law (forbes.com)
- FDA hacked, pharmaceutical companies push for online security audit (medcitynews.com)
- We Moved Forward on Many Fronts This Year | FDA Voice (drughealth.blogspot.com)
Leave a Reply